Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Invicta Diagnostic Ltd. Share Price
Day's Range
Low
₹66.00
High
₹70.50
Price Summary
| Previous Close | ₹66.90 |
|---|---|
| Day's Range | ₹66.00 - ₹70.50 |
| Open | ₹70.50 |
| 52 Week Range | ₹58.10 - ₹105.00 |
| Volume | 30,400 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 20.25 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 17.14 |
| TTM EPS (₹) | 3.90 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 1.64 |
| PAT Margin (%) | 16.38 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 42.85 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 300.95 |
| Expenses | N/A | N/A |
| PBT | N/A | 65.63 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 49.3 |
About Invicta Diagnostic Ltd.
| Founded | 2023 |
|---|---|
| NSE Symbol | INVICTA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,46,276.30 | 1,860.00 | 1,580.00 - 1,580.00 |
| Divi's Laboratories Ltd. | 2,51,531.48 | 9,475.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,86,956.51 | 4,915.15 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,25,119.97 | 8,701.90 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,19,221.66 | 1,195.20 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,17,229.24 | 673.95 | 0.00 - 0.00 |
| Cipla Ltd. | 1,11,728.51 | 1,383.00 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,07,284.39 | 1,985.60 | 826.20 - 826.20 |
| Mankind Pharma Ltd. | 1,05,119.98 | 2,545.00 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,04,335.04 | 1,250.00 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Thyrocare Technologies informs about newspaper publication
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, Thyrocare Technologies has informed that it enclosed copy of the Postal Ballot Notice published in Newspapers i.e. in ‘Business Standard’ (English) and ‘Navshakti’ (Marathi), intimating completion of sending of Postal Ballot Notices, E-voting period, etc. The above information shall also be available on the website of the Company at https://investor.thyrocare.com/.
The above information is a part of company’s filings submitted to BSE.
Syschem India informs about updates
Gland Pharma informs about newspaper publication
Smruthi Organics informs about closure of trading window
Family Care Hospitals informs about SAST
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Invicta Diagnostic Ltd. is ₹66.90 as of 2026-09-28.
The market capitalisation of Invicta Diagnostic Ltd. is ₹84.11 as of 2026-09-28.
The 1-year return of Invicta Diagnostic Ltd. is % as of .
The P/E ratio of Invicta Diagnostic Ltd. is 0.00 as of 2026-09-30.
The 52-week high and low of Invicta Diagnostic Ltd. are ₹105.00 and ₹58.10, respectively, as of 2026-09-28.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
